Fig. 1. Effect of the part of A. cordata on NO production in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were pretreated with AC-S, AC-R and AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 18 hours. The determination of NO production was measured by Griess assay. (B) RAW264.7 cells were treated with AC-L at the indicated concentrations for 24 hours. Cell viability was measured using MTT assay system and expressed as % cell viability. *P < 0.05 compared to the cells without the treatment, and #P < 0.05 compared to the cells treated with LPS alone.
Fig. 2. The effect of AC-L on NO production and iNOS, COX-2 and IL-1β expression in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were pre-treated with AC-L at the indicated concentrations for 6 hours and then co-treated with LPS (1 ㎍/㎖) for the additional 18 hours. After treatment, NO production was measured using the media and Griess reagent and (B) cell lysates were resolved by SDS-PAGE, transferred to nitrocellulose membrane, and probed with iNOS and COX-2 antibody for Western blot. iNOS and COX-2 protein was visualized using ECL was used as a vehicle. (C) For RT-PCR, RAW264.7 cells were pre-treated with AC-L at the indicated concentrations for 6 hours and then co-treated with LPS (1 ㎍/㎖) for the additional 18 hours. Total RNA was isolated and RT-PCR was performed for iNOS and COX-2 and IL-1â. Values given are the mean ± SD (n = 3). *P < 0.05 compared to LPS treatment without AC-L. GAPDH was used as an internal control for RT-PCR.
Fig. 3. The effect of AC-L on NF-κB signaling activation in LPS-stimulated RAW264.7 cells. (A) RAW264.7 cells were pretreated with AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 20 minutes. (B) RAW264.7 cells were pretreated with AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 30 minutes. After the treatment, the cytosol and nucleus were prepared. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against Iκ B-α and p65. Actin was used as internal control.
Fig. 4. The effect of AC-L on MAPK signaling activation in LPS-stimulated RAW264.7 cells. RAW264.7 cells were pretreated with AC-L for 6 hours and then co-treated with LPS (1 ㎍/㎖) for 30 minutes. For Western blot analysis, the cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against p-ERK1/2, p-p38 and Total p-38 and Total ERK1/2 were used as internal control.
References
- Bogdan, C. 2015. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 36:161-178. https://doi.org/10.1016/j.it.2015.01.003
-
Chen, X., S.A. Tang, E. Lee, Y. Qiu, R. Wang, H.Q. Duan, S. Dan, M. Jin and D. Kong. 2015. IVSE, isolated from Inula japonica, suppresses LPS-induced NO production via NF-
${\kappa}B$ and MAPK in activation in RAW264.7 cells. Life Sci. 124:8-15. https://doi.org/10.1016/j.lfs.2015.01.008 -
Dolcet, X., D. Llobet, J. Pallares and X. Matias-Guiu. 2005. NF-
${\kappa}B$ in development and progression of human cancer. Virchows Arch. 446:475-482. https://doi.org/10.1007/s00428-005-1264-9 - Gantke, T., S. Sriskantharajah, M. Sadowski and S.C. Ley. 2012. IkappaB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 246:168-182. https://doi.org/10.1111/j.1600-065X.2012.01104.x
-
Gloire, G., S. Legrand-Poels and J. Piette. 2006. NF-
${\kappa}B$ activation by reactive oxygenspecies: fifteen years later. Biochem Pharmacol. 72:1493-1505. https://doi.org/10.1016/j.bcp.2006.04.011 - Guzik, T.J., T. Korbut and T. Admek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54:469-487.
-
Ha, S.K., E. Moon and S.Y. Kim. 2010. Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-
${\kappa}B$ and JNK activations in microglia cells. Neurosci. Lett. 485:143-147. https://doi.org/10.1016/j.neulet.2010.08.064 - Kang, C.H., J.R. Koo and J.S. So. 2012. Inhibitory effects of Aralia cordata Thunb. extracts in nitric oxide synthesis in RAW264.7 macrophage cells. Korean J. Food Sci. Technol. 44:621-627. https://doi.org/10.9721/KJFST.2012.44.5.621
- Kim, H.N., S.B. Park, G.H. Park, H.J. Eo, J.H. Song, H.Y. Kwon and J.B. Jeong. 2018. Anti-inflammatory effect of the root extracts from Hibiscus syriacus in LPS-stimulated RAW264.7 cells. Korean J. Plant Res. 31:211-217.
-
Lawrence, T. 2009. The Nuclear Factor NF-
${\kappa}B$ Pathway in Inflammation. Cold Spring Harb Perspect Biol. 1:a001651. - Lim, H., H.A. Jung, J.S. Choi, Y.S. Kim, S.S. Kang and H.P. Kim. 2009. Anti-inflammatory activity of the constituents of the roots of Aralia continentalis. Arch Pharm Res. 32:1237-1243. https://doi.org/10.1007/s12272-009-1909-3
- Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064. https://doi.org/10.1096/fasebj.6.12.1381691
-
Nishikori, M. 2005. Classical and alternative NF-
${\kappa}B$ activation pathways and their roles in lymphoid malignancies. J. Clin. Exp. Hematopathol. 45:15-24. https://doi.org/10.3960/jslrt.45.15 - Park, G.H., J.H. Park, H.J. Eo, H.M. Song, M.H. Lee, J.R. Lee and J.B. Jeong. 2014. Anti-inflammatory effect of the extracts from Abeliophyllum distichum Nakai in LPS-stimulated RAW264.7 cells. Korean J. Plant Res. 27:209-214. https://doi.org/10.7732/kjpr.2014.27.3.209
-
Sun, P., Zhou. K, S. Wang, P. Li, S. Chen, G. Lin, Y. Zhao and T. Wang. 2013. Involvement of MAPK/NF-
${\kappa}B$ signaling in the activation of the cholinergic anti-Inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One 8:e69424. https://doi.org/10.1371/journal.pone.0069424 - Surh, Y.J., K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park and S.S. Lee. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Research 480-481:243-268. https://doi.org/10.1016/S0027-5107(01)00183-X
-
Taniguchi, K. and M. Karin. 2018. NF-
${\kappa}B$ , inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 18:309-324. https://doi.org/10.1038/nri.2017.142 - Tsuzaki, M., D. Bynum, L. Almekinders, X. Yang, J. Faber and A.J. Banes. 2003. ATP modulates load-inducible IL-1beta, COX 2, and MMP-3 gene expression in human tendon cells. J Cell Biochem. 1:556-562.
- Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735. https://doi.org/10.1101/gad.9.22.2723
- Wang, D. and R.N. Dubois. 2010. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 9:781-788.
- Zarghi, A. and S. Arfaei. 2011. Selective COX-2 inhibitors: A review of their structure-activity relationships. Iran J Pharm Res. 10:655-683.
Cited by
- Anti-inflammatory effects of 18-nor-ent-pimara-9(11),15-diene-4β-ol isolated from the roots of Aralia continentalis on LPS-induced in RAW264.7 cells vol.63, pp.1, 2018, https://doi.org/10.1186/s13765-020-00553-7